All Stories

  1. Reduced PPOX Expression Causes Intrinsic Pathogenicity in Keratinocytes, Contributing to the Cutaneous Variegate Porphyria Phenotype
  2. Choice of gDNA isolation method has a significant impact on average murine Telomere Length estimates
  3. BS18 Loss of full-length MYLK3 causes dilated cardiomyopathy via a MYL2-independent mechanism.
  4. Ichthyosis linked to sphingosine 1-phosphate lyase insufficiency is due to aberrant sphingolipid and calcium regulation
  5. Characterization of dominant-negative growth hormone receptor variants reveals a potential therapeutic target for short stature
  6. Elevated sphingosine-1-phosphate lyase leads to increased metabolism and reduced survival in adrenocortical carcinoma
  7. Adrenal Dysfunction in Mitochondrial Diseases
  8. Abstract P2005: Loss Of Full-length Mylk3 Causes Dilated Cardiomyopathy Via A MYL2-independent Mechanism
  9. Insights From Long-term Follow-up of a Girl With Adrenal Insufficiency and Sphingosine-1-Phosphate Lyase Deficiency
  10. Exome Sequencing Identifies a Novel FBN1 Variant in a Pakistani Family with Marfan Syndrome That Includes Left Ventricle Diastolic Dysfunction
  11. Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause
  12. Loss of Nnt Increases Expression of Oxidative Phosphorylation Complexes in C57BL/6J Hearts
  13. Genetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years’ Experience in the UK
  14. Sphingosine-1-phosphate lyase (SGPL1) deficiency is associated with mitochondrial dysfunction
  15. Mylk3null C57BL/6N mice develop cardiomyopathy, whereasNntnull C57BL/6J mice do not
  16. GHR gene transcript heterogeneity may explain phenotypic variability in GHR pseudoexon (6Ψ) patients
  17. Long-term outcome of partial P450 side-chain cleavage enzyme deficiency in three brothers: the importance of early diagnosis
  18. ACTH signalling and adrenal development: lessons from mouse models
  19. Isolated Glucocorticoid Deficiency: genetic causes and animal models
  20. SGPL1 Deficiency: A Rare Cause of Primary Adrenal Insufficiency
  21. Predicted Benign and Synonymous Variants in CYP11A1 Cause Primary Adrenal Insufficiency Through Missplicing
  22. Nonclassical GH Insensitivity: Characterization of Mild Abnormalities of GH Action
  23. HS6ST1 Insufficiency Causes Self-Limited Delayed Puberty in Contrast With Other GnRH Deficiency Genes
  24. MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation
  25. Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation
  26. Nicotinamide Nucleotide Transhydrogenase as a Novel Treatment Target in Adrenocortical Carcinoma
  27. Phenotypic spectrum and responses to recombinant human IGF1 (rhIGF1) therapy in patients with homozygous intronic pseudoexon growth hormone receptor mutation
  28. NNT is a key regulator of adrenal redox homeostasis and steroidogenesis in male mice
  29. Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells
  30. Whole-exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity
  31. In-frame seven amino-acid duplication in AIP arose over the last 3000 years, disrupts protein interaction and stability and is associated with gigantism
  32. Novel Dominant-Negative GH Receptor Mutations Expands the Spectrum of GHI and IGF-I Deficiency
  33. Sphingosine-1-phosphate lyase mutations cause primary adrenal insufficiency and steroid-resistant nephrotic syndrome
  34. Three-Dimensional Model of Human Nicotinamide Nucleotide Transhydrogenase (NNT) and Sequence-Structure Analysis of its Disease-Causing Variations
  35. IGSF10mutations dysregulate gonadotropin‐releasing hormone neuronal migration resulting in delayed puberty
  36. Role of IGSF10 mutations in self-limited delayed puberty
  37. Primary Adrenocortical Insufficiency Case Series: Genetic Etiologies More Common than Expected
  38. Genetic characterisation of children with short stature and GH or IGF1 insensitivity by single gene and whole exome sequencing
  39. Dominant negative STAT5B variants in two families with mild GH insensitivity and eczema
  40. Molecular diagnosis of patients with adrenal insufficiency using a targeted custom Haloplex next-generation sequencing panel
  41. RNA-sequencing of mouse adrenals reveals the pathways perturbed by loss of nicotinamide nucleotide transhydrogenase
  42. Nicotinamide nucleotide transhydrogenase (NNT) as a novel molecular target in adrenocortical carcinoma - impact of NNT knockdown on adrenocortical cell proliferation, redox balance and steroidogenesis
  43. Whole-Exome Sequencing in the Differential Diagnosis of Primary Adrenal Insufficiency in Children
  44. Genetic characterisation of a cohort of children clinically labelled as GH or IGF1 insensitive: diagnostic value of serum IGF1 and height at presentation
  45. NNTPseudoexon Activation as a Novel Mechanism for Disease in Two Siblings With Familial Glucocorticoid Deficiency
  46. Heterogeneity of the growth phenotype and birth size in acid-labile subunit (ALS) deficiency
  47. Molecular Genetics of Inherited Glucocorticoid Deficiency
  48. Varied clinical presentations of six patients with mutations in CYP11A1 encoding the cholesterol side-chain cleavage enzyme, P450scc
  49. cDNA analysis reveals NNT pseudoexon activation in two siblings with familial glucocorticoid deficiency
  50. A heterozygous STAT5B variant in a family with short stature and transient hyperprolactinaemia: a possible dominant negative effect
  51. Thioredoxin Reductase 2 (TXNRD2) Mutation Associated With Familial Glucocorticoid Deficiency (FGD)
  52. Mitochondrial thiol systems are important players in antioxidant defence for the human adrenal cortex
  53. IGFALS Gene Dosage Effects on Serum IGF-I and Glucose Metabolism, Body Composition, Bone Growth in Length and Width, and the Pharmacokinetics of Recombinant Human IGF-I Administration
  54. Oxidative stress and adrenocortical insufficiency
  55. A novel gene affecting the timing of puberty
  56. A Novel Homozygous Mutation of the <b><i>IGFALS</i></b> Gene in a Female Adolescent: Indirect Evidence for a Contributing Role of the Circulating IGF-I Pool in the Pubertal Growth Spurt
  57. Deficiency of ALADIN Impairs Redox Homeostasis in Human Adrenal Cells and Inhibits Steroidogenesis
  58. Genome sequencing reveals mitochondrial thiol systems are essential for antioxidant defence in human adrenal glands
  59. Familial glucocorticoid deficiency: a diagnostic challenge during acute illness
  60. Familial glucocorticoid deficiency: New genes and mechanisms
  61. Familial constitutional delay in growth and puberty is a condition with significant genetic heterogeneity and limited overlap with the timing of puberty in the general population
  62. A mutation in thioredoxin reductase 2 (TXNRD2) is associated with a predominantly adrenal phenotype in humans
  63. ACTH Resistance: Genes and Mechanisms
  64. Adrenocortical Development, Maintenance, and Disease
  65. A homozygous glutathione peroxidase 1 mutation, p. Arg130-Leu133del, in a patient with familial glucocorticoid deficiency
  66. Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency
  67. An Atypical Case of Familial Glucocorticoid Deficiency without Pigmentation Caused by Coexistent Homozygous Mutations inMC2R(T152K) andMC1R(R160W)
  68. MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans
  69. Neonatal presentation of familial glucocorticoid deficiency resulting from a novel splice mutation in the melanocortin 2 receptor accessory protein
  70. Severe Cortisol Deficiency Associated with Reversible Growth Hormone Deficiency in Two Infants: What Is the Link?
  71. Evidence for a Continuum of Genetic, Phenotypic, and Biochemical Abnormalities in Children with Growth Hormone Insensitivity
  72. Effects of melanocortins on adrenal gland physiology
  73. 5.10 Familial glucocorticoid deficiency
  74. 7.2.3 Genetic defects of the human somatotropic axis
  75. Genetic Defects in the Growth Hormone?IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear Growth
  76. Repair of Aberrant Splicing in Growth Hormone Receptor by Antisense Oligonucleotides Targeting the Splice Sites of a Pseudoexon
  77. Missense Mutations in the Melanocortin 2 Receptor Accessory Protein That Lead to Late Onset Familial Glucocorticoid Deficiency Type 2
  78. Missense Mutations in the Melanocortin 2 Receptor Accessory Protein That Lead to Late Onset Familial Glucocorticoid Deficiency Type 2
  79. Repair of Aberrant Splicing in Growth Hormone Receptor by Antisense Oligonucleotides Targeting the Splice Sites of a Pseudoexon
  80. Missense Mutations in the Melanocortin 2 Receptor Accessory Protein That Lead to Late Onset Familial Glucocorticoid Deficiency Type 2
  81. Repair of Aberrant Splicing in Growth Hormone Receptor by Antisense Oligonucleotides Targeting the Splice Sites of a Pseudoexon
  82. d3‐GHR genotype does not explain heterogeneity in GH responsiveness in hypopituitary adults
  83. Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2
  84. Acid-Labile Subunit Deficiency and Growth Failure: Description of Two Novel Cases
  85. Familial Isolated Primary Pigmented Nodular Adrenocortical Disease Associated with a Novel Low Penetrance <i>PRKAR1A</i> Gene Splice Site Mutation
  86. Isolated Addison's disease is unlikely to be caused by mutations in MC2R, MRAP or STAR, three genes responsible for familial glucocorticoid deficiency
  87. Identification and characterisation of a novel GHR defect disrupting the polypyrimidine tract and resulting in GH insensitivity
  88. Nonclassic Lipoid Congenital Adrenal Hyperplasia Masquerading as Familial Glucocorticoid Deficiency
  89. Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency (FGD) are not associated with long‐term mineralocorticoid deficiency
  90. MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family
  91. The genetics of familial glucocorticoid deficiency
  92. Accessory proteins are vital for the functional expression of certain G protein-coupled receptors
  93. Functional consequence of a novel Y129C mutation in a patient with two contradictory melanocortin-2-receptor mutations
  94. Phenotypic Aspects of Growth Hormone- and IGF-I-Resistant Syndromes
  95. The Majority of Adrenocorticotropin Receptor (Melanocortin 2 Receptor) Mutations Found in Familial Glucocorticoid Deficiency Type 1 Lead to Defective Trafficking of the Receptor to the Cell Surface
  96. OR9,3 Acid-labile subunit gene mutations: clinical, biochemical and molecular study in two unrelated families
  97. Adrenocorticotropin Resistance Syndromes
  98. Familial Glucocorticoid Deficiency: Advances in the Molecular Understanding of ACTH Action
  99. Clinical and biological phenotype of a patient with familial glucocorticoid deficiency type 2 caused by a mutation of melanocortin 2 receptor accessory protein
  100. The TPIT Gene Mutation M86R Associated with Isolated Adrenocorticotropin Deficiency Interferes with Protein: Protein Interactions
  101. Idiopathic short stature: will genetics influence the choice between GH and IGF-I therapy?
  102. Novel polymorphisms and lack of mutations in the ACD gene in patients with ACTH resistance syndromes
  103. An Intronic Growth Hormone Receptor Mutation Causing Activation of a Pseudoexon Is Associated with a Broad Spectrum of Growth Hormone Insensitivity Phenotypes
  104. Growth Hormone Insensitivity and Severe Short Stature in Siblings: A Novel Mutation at the Exon 13-Intron 13 Junction of the <i>STAT5b</i> Gene
  105. The genetics of ACTH resistance syndromes
  106. Severe loss‐of‐function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt‐losing adrenal hypoplasia
  107. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders
  108. Mechanisms of Disease: the adrenocorticotropin receptor and disease
  109. A 36 residues insertion in the dimerization domain of the growth hormone receptor results in defective trafficking rather than impaired signaling
  110. Inherited ACTH insensitivity illuminates the mechanisms of ACTH action
  111. Diagnostic and Therapeutic Advances in Growth Hormone Insensitivity
  112. Genetics of ACTH insensitivity syndromes
  113. Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2
  114. Novel Growth Hormone Receptor Mutation in a Chinese Patient with Laron Syndrome
  115. TPIT mutations are associated with early-onset, but not late-onset isolated ACTH deficiency
  116. Growth Hormone (GH) Insensitivity Syndrome due to a GH Receptor Truncated after Box1, Resulting in Isolated Failure of STAT 5 Signal Transduction
  117. Mutations in a Novel Gene, Encoding a Single Transmembrane Domain Protein Are Associated with Familial Glucocorticoid Deficiency Type 2
  118. Reduced expression of the growth hormone and type 1 insulin‐like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor
  119. Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity
  120. Detection of rpoB Mutations in Mycobacterium tuberculosis by Biprobe Analysis
  121. Pseudoexon Activation as a Novel Mechanism for Disease Resulting in Atypical Growth-Hormone Insensitivity
  122. Growth Hormone Insensitivity: Pathophysiology, Diagnosis, Clinical Variation and Future Perspectives
  123. Tall stature in familial glucocorticoid deficiency
  124. NOSOCOMIAL ACQUISITION OFBURKHOLDERIA GLADIOLIIN PATIENTS WITH CYSTIC FIBROSIS
  125. PCR–Enzyme-Linked Immunosorbent Assay for Detection and Identification of Campylobacter Species: Application to Isolates and Stool Samples
  126. Predictive modelling of fluorescent AFLP: a new approach to the molecular epidemiology of
  127. Investigation of an outbreak of multidrug resistant tuberculosis among renal patients using rpo B genes sequencing and IS6110 inverse PCR
  128. Rapid, sensitive, microbial detection by gene amplification using restriction endonuclease target sequences
  129. Outbreak of septicaemia in neonates caused by Acinetobacter junii investigated by amplified ribosomal DNA restriction analysis (ARDRA) and four typing methods
  130. Utility of Polycation-Treated Filters for the Assay of Receptors for VIP
  131. IGF-I Deficiency: Lessons from Human Mutations